Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bielack

Showing results (51-60 of 184) with videos related to

Pageof 19
Sort By:
Cancer Treatment and Research|January 1, 1993
Treatment of osteosarcoma: experience of the Cooperative Osteosarcoma Study Group (COSS)K Winkler, S S Bielack, G Delling, et al.
Medical and Pediatric Oncology|January 1, 1995
Osteosarcoma of the trunk treated by multimodal therapy: experience of the Cooperative Osteosarcoma study group (COSS)S S Bielack, B Wulff, G Delling, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Platinum disposition after intraarterial and intravenous infusion of cisplatin for osteosarcoma. Cooperative Osteosarcoma Study Group COSSS S Bielack, R Erttmann, G Looft, et al.
European Journal of Pediatrics|January 29, 2000
The course of fibrinolytic proteins in children with malignant bone tumoursU Nowak-Göttl, N Münchow, U Klippel, et al.
Ecancermedicalscience|August 19, 2015
Conference report on the 28th annual meeting of the European Musculo-Skeletal Oncology Society, 29 April-1 May 2015, AthensAndreas Leithner, Dimosthenis Andreou, Robert Grimer, et al.
Minerva Pediatrica|April 25, 2013
Controversies in childhood osteosarcomaS Bielack, B Kempf-Bielack, T Von Kalle, et al.
Klinische Padiatrie|July 1, 1991
[Cardiomyopathy after osteosarcoma treatment: a contribution to the cardiotoxicity of adriamycin]S Geidel, M Garn, L Grävinghoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2010
Metastasis of osteosarcoma after 16 yearsJana Ellegast, Thomas F E Barth, Michael Schulte, et al.
Cancer Investigation|June 11, 2005
Cisplatin-induced ototoxicity in osteosarcoma patients: a report from the late effects surveillance systemW Stöhr, T Langer, A Kremers, et al.
Klinische Padiatrie|May 14, 2009
Networking for children and adolescents with very rare tumors: foundation of the GPOH Pediatric Rare Tumor GroupI B Brecht, N Graf, D von Schweinitz, et al.
Pageof 19

Showing results (51-60 of 184) with videos related to

Sort By:
Pageof 19
Cancer Treatment and Research|January 1, 1993
Treatment of osteosarcoma: experience of the Cooperative Osteosarcoma Study Group (COSS)K Winkler, S S Bielack, G Delling, et al.
Medical and Pediatric Oncology|January 1, 1995
Osteosarcoma of the trunk treated by multimodal therapy: experience of the Cooperative Osteosarcoma study group (COSS)S S Bielack, B Wulff, G Delling, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Platinum disposition after intraarterial and intravenous infusion of cisplatin for osteosarcoma. Cooperative Osteosarcoma Study Group COSSS S Bielack, R Erttmann, G Looft, et al.
European Journal of Pediatrics|January 29, 2000
The course of fibrinolytic proteins in children with malignant bone tumoursU Nowak-Göttl, N Münchow, U Klippel, et al.
Ecancermedicalscience|August 19, 2015
Conference report on the 28th annual meeting of the European Musculo-Skeletal Oncology Society, 29 April-1 May 2015, AthensAndreas Leithner, Dimosthenis Andreou, Robert Grimer, et al.
Minerva Pediatrica|April 25, 2013
Controversies in childhood osteosarcomaS Bielack, B Kempf-Bielack, T Von Kalle, et al.
Klinische Padiatrie|July 1, 1991
[Cardiomyopathy after osteosarcoma treatment: a contribution to the cardiotoxicity of adriamycin]S Geidel, M Garn, L Grävinghoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2010
Metastasis of osteosarcoma after 16 yearsJana Ellegast, Thomas F E Barth, Michael Schulte, et al.
Cancer Investigation|June 11, 2005
Cisplatin-induced ototoxicity in osteosarcoma patients: a report from the late effects surveillance systemW Stöhr, T Langer, A Kremers, et al.
Klinische Padiatrie|May 14, 2009
Networking for children and adolescents with very rare tumors: foundation of the GPOH Pediatric Rare Tumor GroupI B Brecht, N Graf, D von Schweinitz, et al.
Pageof 19